Brazil Daily

Brazilian regulators suspend CoronaVac trial

Today, we explain Brazil’s latest coronavirus vaccine controversy. Brazil’s place among the world’s top economies. And a setback for reducing carbon emissions.

Brazil halts Chinese vaccine tests

Citing an unspecified “severe adverse event,” Brazil’s Health Surveillance Agency (Anvisa) suspended clinical trials of the CoronaVac — the potential Covid-19 vaccine being developed by Chinese pharmaceutical company Sinovac Biotech and tested in Brazil by the state government of São Paulo. The trial organizers countered the information, saying the regulators based their decision on the death of a volunteer in the study that was unrelated to the vaccine.

  • The state of São Paulo...
Access all of The Brazilian Report

Less expensive than a coffee!

Enjoy your 30-day limited-time offer for US$ 0.25 a week